Matthew R. Kane Precision Biosciences Inc (DTIL) insider trading activity

Matthew R. Kane is President and CEO of PRECISION BIOSCIENCES INC. Currently has a direct ownership of 2.01 Million shares of DTIL, which is worth approximately $14.6 Million. The most recent transaction as insider was on Jan 26, 2021, when has been sold 9,697 shares (Common Stock) at a price of $13.37 per share, resulting in proceeds of $129,649. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.01M

0% 3M change

0% 12M change

Total Value Held $14.6 Million

MATTHEW R. KANE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 26 2021	SELL Open market or private sale	$129,649 $13.37 p/Share	9,697 Reduced 0.52%	1,854,011 Common Stock
Jan 26 2021	BUY Exercise of conversion of derivative security	$861 $0.04 p/Share	21,515 Added 1.14%	1,863,708 Common Stock
Jan 25 2021	SELL Open market or private sale	$133,209 $13.74 p/Share	9,695 Reduced 0.52%	1,842,193 Common Stock
Jan 25 2021	BUY Exercise of conversion of derivative security	$861 $0.04 p/Share	21,514 Added 1.15%	1,851,888 Common Stock
Jan 22 2021	SELL Open market or private sale	$138,250 $13.53 p/Share	10,218 Reduced 0.56%	1,830,374 Common Stock
Jan 22 2021	BUY Exercise of conversion of derivative security	$861 $0.04 p/Share	21,514 Added 1.16%	1,840,592 Common Stock

MRK

Matthew R. Kane

President and CEO

Durham, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DTIL shares.

Notify only if

Value

Insider Trading

Get notified when an Precision Biosciences Inc insider buys or sells DTIL shares.

Notify only if

Operation

Value

Type

News

Receive news related to PRECISION BIOSCIENCES INC

Track Activities on DTIL

Account